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Floppy eyelid syndrome: review
Síndrome da frouxidão palpebral: revisão da literatura
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RESUMO
A síndrome de frouxidão palpebral é caracterizada pela fácil eversão da pálpebra
que ocorre espontaneamente durante o sono causando exposição dos olhos, com
consequente conjuntivite papilar crônica. Sua patogênese ainda não está totalmen-
te definida e é mais comum em pacientes masculinos, obesos, de meia idade e está
associada a doenças sistêmicas como apnéia obstrutiva do sono, hipertensão arte-
rial e diabetes. Quando o tratamento clínico não apresenta boa resposta, procedi-
mentos cirúrgicos apresentam bons resultados, com técnicas em constante evolução.
Descritores: Conjuntiva/patologia; Conjuntivite; Ectrópio; Obesidade/complicações;
Hipertensão/complicações; Diabete Mellitus/complicações; Apnéia do sono tipo
obstrutiva/complicações; Doenças palpebrais/cirurgia; Síndrome; Músculos ocu-
lomotores/cirurgia; Pálpebras/cirurgia; Doenças da córnea
ABSTRACT
Floppy eyelid syndrome is characterized by the easy evertion of the upper eyelid
which occurs spontaneously during the sleep, causing the exposure of the eye
surface and chronic papillary conjunctivitis. Its pathogenesis is not totally defined yet:
it is usually more frequent in middle-aged, male obese patients and it is associated
with systemic disorders such as obstructive sleep apnea, high blood pressure and
diabetes. On the occasions which conservative treatment fails, surgical procedures
present good results, including surgical techniques which are constantly evolving.
Keywords: Conjunctiva/pathology; Conjunctivitis; Ectropion; Obesity/complications;
Hypertension/complications; Diabetes Mellitus/complications; Sleep apnea, obs-
tructive/complications; Eyelid diseases/surgery; Syndrome; Oculomotor Muscles/
surgery; Eyelids/surgery; Corneal diseases
INTRODUCTION
F loppy eyelid syndrome (FES), first reported in 1981 by Culbertsonand Ostler(1), is recognized by a loose upper lid that readi-ly everts by pulling it upward(1) (Figure1), a soft, rubbery tarsus
that can be easily folded(2), and chronic papillary conjunctival res-
ponse(1,3). Patients with this syndrome generally complain about non-
specific irritation, foreign body sensation, mucoid discharge, dryness,
redness, photosensitivity, eyelid swelling and decreased vision(4-5).
These symptoms are usually worse on awakening in the mor-
ning, and the affected side seems to correspond to the side the patient
usually sleeps(1). In most cases, the patient is chronically treated
with topical therapeutic agents with no response. Although initially
reported to be typical in middle-aged overweight men(1,3), FES has
also been found in women, different age groups, and no obese
patients(6-7). The syndrome is not completely understood and it may
be associated with many systemic and ophthalmic diseases such as
obesity, obstructive sleep apnea, hypertension, ischemic heart
disease, skin and collagen pathologies, corneal and eyelids abnor-
malities and glaucoma.
The treatment is basically surgical, however clinical manage-
ment, like eye shields, lubricants and weight loss can be efficient in
some cases. The purpose of this article is to make a review of floppy
eyelid syndrome emphasizing the main associated conditions,
theories about its pathogenesis, and treatments.
PATHOGENESIS
Since the initial description of the floppy eyelid syndrome in 1981,
several hypotheses have been made for its pathogenesis. Culber-
tson and Ostler(1), who first pointed out this condition, postulated
that spontaneous nocturnal eversion of the upper eyelid would
cause events, such as mechanical insult to the conjunctiva, subse-
quent papillary conjunctivitis and conjunctival keratinization lea-
ding to the loss of tarsal elasticity. They made this hypothesis based
on the observation that the ocular signs and symptoms are general-
ly more frequent and/or more severe in the eye corresponding to
the side on which the patient prefers to sleep. They also suggested
an X-chromosome-linked inheritance pattern or hormone influen-
ce associated to the problem, since they only found it in men.
Parunovic(2), however, proposed that the laxity of the lids was the
cause of the irritative symptoms mentioned by the patients. The
reduced interface between the loose eyelids and the epibulbar
surface would compromise the distribution of the tear film over
the cornea and conjunctiva, producing poor wetting and subse-
quent ocular surface disease. This proposition was based on diffuse
keratitis found in FES different of that one usually localized resul-
ting from nocturnal exposure. Schwartz et al.(8) and Goldberg et al.(9)
also suggested this mechanism of injury.
Later, other researchers postulated that a genetically predispo-
sition, like genetic abnormalities in collagen, elastin, or both, asso-
ciated with age and sleeping patterns, would cause the FES(3,10). The
obstructive sleep apnea (OSA), often present in patients with FES,
lead to the hypothesis that a common underlying connective tissue
disorder would explain the syndrome. Redundancy of tissue in the
tarsal plate of lateral canthal tendons might contribute to the
development of FES, like the excess of oropharyngeal tissues found
in OSA cause upper airway obstruction specially when the person is
sleeping(3,11-12).
Inflammation was also pointed out as a contributing factor to
FES. Since blepharochalasis and FES share many of the same ocular
findings and significant chronic inflammation are encountered in
both conditions, a theory of a common inflammatory pathway was
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made. Inflammation would cause generalized atrophy and attenua-
tion of muscles, tendons and ligaments. Nevertheless, histological
studies of the tarsus showed normal structure along with the pre-
sence of chronic inflammatory infiltrate(3,11).
Hyperglycinemia was another condition that was speculated to
be involved in the pathogenesis of FES, because glycine is present
in high concentrations in collagen and gelatin, and a patient with
floppy lids and hyperglycinemia was described. The high concen-
tration of glycine in collagen would induce structural changes in
the tarsus(6). Goldberg et al., however, observed that hyperglycine-
mia is not classically associated with collagen disorders(9).
Another theory claims that a combination of local pressure-indu-
ced lid ischemia and systemic hypoventilation followed by reper-
fusion oxidation injury during sleep (sleep apnea) is responsible for
changes, such as chronic inflammation, which leads to higher tem-
perature and lost of the normal barrier against water evaporation. This,
in turn, would cause additional damage to the skin and this vicious
cycle would aggravate lid inflammation, contributing to meibomian
gland dysfunction, a condition that might be associated with FES(12)
and lid floppiness(4). The nonspecific ocular surface irritation related
with FES might be due to abnormality in tear film dynamics. There
is a high correlation between the eye with worse symptoms with
more severe floppy lids and the ocular surface evaporation rate.
Tear film alterations is prevalent in patients with FES, most of them
due to lipid tear deficiency(4), which might be caused by abnorma-
lities of meibomian glands(12).
Since the main finding in FES is the laxity of the lids, as the name
of the syndrome suggests, it was postulated that alterations in
collagen would explain this condition. In fact, mutations in the type V
collagen genes COL5A1 and COL5A2 were found in patients with
ocular phenotype of classic Ehlers-Danlos syndrome (EDS), a disea-
se characterized by laxity and fragility of soft connective tissues.
Type V collagen is a quantitatively minor fibril-forming collagen that
is present in type I collagen-rich connective tissues such as dermis,
tendon and ligament. Mechanisms producing the abnormalities in
those tissues were probably associated with altered regulation of
collagen fibrillogenesis due to alterations in heterotypic I/V colla-
gen interactions(5). Meanwhile, tarsal collagen appeared normal
using hematoxylin-eosin and Masson trichrome stains in eyelid
biopsy specimens of FES patients, and electron microscopy sho-
wed that the quantity of collagen in the tarsus was normal. Also, the
localization of collagen types I and III was similar in patients with FES
and controls(12).
Reduced amount of tarsal elastin was observed in patients with
FES by immunohistochemical studies using Verhoeff’s modified elas-
tin stain suggesting that abnormal elastogenesis might be associa-
ted with this syndrome(12). The marked decrease in the amount of
elastin within the tarsal plate and eyelid skin, however, might be
explained by an up-regulation of elastolytic enzymes, particularly
matrix metalloproteinases 7 and 9 (MMP-7 and MMP-9), most proba-
bly stimulated by repeated mechanical stress, like eye rubbing and
sleeping habits. This up-regulation could also be the cause of eyelash
misdirection frequently found in FES(10). The up-regulation of ma-
trix metalloproteinase (MMP) expression, by the way, might be due
to elevated levels of leptin that has been shown to regulate the
expression of MMP-9 in a dose-dependent manner. Besides, hyper-
leptinemia correlates positively with the severity of obstructive sleep
apnea (OSA), a condition frequently present in patients with FES.
Therefore, hyperleptinemia may be involved in the pathogenesis of
both FES and OSA(5).
CORNEAL ABNORMALITY AND SYSTEMIC CONDITIONS RELATED
WITH FLOPPY EYELID SYNDROME
Corneal abnormality
Culbertson and Tseng(13), in a retrospective review of 60 patien-
ts with floppy eyelid syndrome followed at the Bascom Palmer Eye
Institute found a prevalence of seventy-one per cent of patients with
clinically significant corneal abnormalities related with FES, that could
affect all layers of cornea. Punctate epithelial keratitis was descri-
bed as the most common corneal disorder, usually diffuse and found
only in the involved eye(13).
Another corneal abnormality reported by Culberston and Tseng(13)
was keratoconus, present in 10% of all patients. FES associated with
keratoconus was also described by Parunovic(2), Donnenfeld et al.(14),
and Negris(15). Corneal endotheliopathy associated with FES was des-
cribed as a progressive non guttate dystrophy and as a possible
Chandler’s variant of the iridocorneal endothelial syndrome(13).
Other corneal signs include subepithelial scarring and deep neo-
vascularization(16).
OBSTRUCTIVE SLEEP APNEA
Obstructive sleep apnea (OSA) is characterized by intermittent
and repeated interruption of airflow during the sleep due to elevated
airway resistance. It causes sleep disorder, waking the patient during
the night, resulting in excessive daytime somnolence. The patient
could present snoring and arterial hypertension. This syndrome is
strongly associated with obesity and FES(17). The diagnosis is made by
polysomnography and the treatment is based in losing weight. Severe
cases may be treated by uvulopalatopharyngoplasty and continuous
positive airway pressure (CPAP). The first case associating this entities
was reported in 1987 by Gonnering and Sonneland(18). In 1989, Gold-
berg et al.(9), described another patient with ectropion due to FES and
sleep disorders that they called Pickwickian respiratory syndrome. No
conclusion between this association had been taken yet.
Figure  1. Young man with floppy eyelid syndrome: ptosis of the cilia (A) and abnormal degree of laxity of the upper eyelid
during minimal lateral traction (B).
A B
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In 1990, Young et al.(17) reported 3 patients with FES and OSA
and proposed a tissue abnormality to correlate these two syndro-
mes. In 1987, Gonnering and Sonelland(18) selected patients with
FES to underwent polysomnography and patients with OSA to be
examined for ocular abnormalities and measurement of vertical
upper lid pull. In a group of 8 patients with FES, all of them had
also OSA in different degrees; however, among 20 patients with
OSA, only one case of FES was diagnosed. Nevertheless, measure-
ment of vertical upper lid pull was significantly higher in these
patients compared with normal population. McNab(18) also showed
one patient with the 2 entities, that improved of FES after treat-
ment of OSA (uvulopalatopharyngoplasty and CPAP), with no papil-
lary conjunctivis and normal lid laxity(19).
In 2005, McNab(20) analyzed 50 patients with FES and found that
96% of them had symptoms of OSA. Seventeen of these patients
were undergone sleep studies and in sixteen (94%) was confirmed
the diagnosis of OSA. This result corroborated with his previous
study showing that patients with FES and OSA had worse degrees
of severity, higher number of apnoeic or hypopnoiec episodes per
hour, and lower minimum saturation of arterial oxygen, when
compared with patients who had only OSA. It suggests that FES is
a severity marker of OSA. In 2006, Karger et al.(21) confirmed McNab
findings. They encountered an association with subjectively easy lid
eversion and sleep disorders, but a low frequency of FES. Accor-
ding to currently data, most of the patients with FES have OSA,
however the opposite is not true. Patients with FES should under-
go polysomnography to evaluate a possible OSA, whose treatment
could give a better life quality to the patient.
Several other systemic conditions have already been associated
with FES, such as diabetes, ischemic heart disease, hypercholeste-
rolemia, osteoarthritis, asthma, gastroesophageal reflux disease,
chronic renal failure, and schizophrenia(22). However, many of these
conditions are directly or indirectly linked with obesity, which may
represent a confounding factor.
TREATMENT
Based on the speculative etiologies of FES, many different kinds
of clinical and surgical treatments were proposed. The clinical
treatment involves losing weight, taping the eyelids during the
night(1), eye shields and topical lubricants(2). Improvement of FES
manifestations by the treatment of OSA with CPAP was seen by
McNab(19).
The surgical techniques changed in the years and are constantly
being improved to treat this condition. Gerner and Hughes(6) first
described a shortening procedure in a patient with hyperglycine-
mia and floppy eyelids. Dutton had also tried an eyelid shortening
procedure, in which a full thickness resection of the lateral one
third to one half of the eyelid was performed with primary layered
closure(23). Later, lateral tarsorrhaphy was used by Bouchard(24).
Karesh et al.(25) had done a similar procedure to Dutton’s by using
a lateral canthal tendon placation, and lower eyelid horizontal
shortening. Despite of the good effectiveness, these procedures do
not have a fine aesthetic result. Therefore, Periman and Sires(26) presen-
ted a modified technique in which a temporally placed, modified
back tapered wedge resection and advancement flap is used to
create a wound and scar that satisfactorily falls within or more nearly
parallel to the eyelid crease, camouflaging it, having a better cosme-
tic result. More recently, Burkat and Lemke(27) described a lateral tarsal
strip fixation to periosteal flaps based inside the orbital rim to
achieve horizontal tightening, with 91% of improvement of symp-
toms in a follow-up of 52 months.
Valenzuela and Sullivan(28) performed, based on the presence of
predominately medial upper laxity, a medial upper eyelid hori-
zontal shortening with an upper eyelid skin reduction when excess
of skin was present, and some other patients also underwent hori-
zontal lower eyelid shortening additionally or not to the lower eyelid
retractor plication. The authors had a great success in 18 months of follow-
up, with relief of the symptoms and good aesthetic appearance.
Besides the surgical management is the main and more effecti-
ve treatment for FES, a long-term study(29) involving 71 patients who
had undergone surgery for FES at Moorfields Eye Hospital demons-
trate significant recurrence rates varying from 25.6% to 60.6% de-
pending on the procedure used. The data provided by this showed
better survival outcomes using the medial canthal and lateral canthal
plication and upper lid lateral tarsal strip procedures in comparison
with the full-thickness wedge excision procedure, which was recom-
mended to be avoided(29).
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